This Article  • Full text  • PDF  • Original Article  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in this journal  Topic Collections  • Neurology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Roger Rosenberg, MD, Editor

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A comparative analysis of the article by Watts et al¹ published in the January 2007 issue of Neurology and the article by Jankovic et al² published in the May 2007 issue of the Archives indicates that these are redundant publications. Each section of both articles contains substantially similar information. Most of the tables and figures and the data in the "Results" sections from both articles are redundant. The Archives article contains some additional data, but this additional information represents a minor contribution.

Despite the considerable similarity between these 2 articles, the Neurology article was not referenced in the manuscript submitted to the Archives in September 2006, nor did the authors inform the editor of the existence of this similar paper as is required in the Archives’ "Instructions for Authors." The Neurology paper had already been accepted when we requested revisions to the manuscript, which was . . . [Full Text of this Article]

AUTHOR INFORMATION



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Notice of Redundant Publication: "Transdermal Rotigotine: Double-blind, Placebo-Controlled Trial in Parkinson Disease" (Arch Neurol. 2007;64[5]:676-682)—Reply
Joseph Jankovic, Ray L. Watts, Wayne Martin, and Babak Boroojerdi
Arch Neurol. 2007;64(12):1801.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Transdermal Rotigotine: Double-blind, Placebo-Controlled Trial in Parkinson Disease
Joseph Jankovic, Ray L. Watts, Wayne Martin, Babak Boroojerdi, and for the SP 512 Rotigotine Transdermal System Clinical Study Group
Arch Neurol. 2007;64(5):676-682.
ABSTRACT | FULL TEXT